Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by The Sunday Roast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Sunday Roast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

S10 Ep41: Midweek Takeaway with Anthony Tennyson, CEO of Solvonis Therapeutics plc (LSE: SVNS) #SVNS

19:48
 
Share
 

Manage episode 499789962 series 3002024
Content provided by The Sunday Roast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Sunday Roast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode of The Midweek Takeaway, Kevin Hornsby and Charles Archer is joined by Anthony Tennyson, CEO of Solvonis Therapeutics (LSE: SVNS), to discuss positive pre-clinical results from the company’s PTSD programme, SVN-SDN-14. Three high-performing candidates with strong, balanced SERT, DAT, and NET modulation profiles are advancing to in vivo studies — a key step toward developing a new class of medicines aimed at enhancing pro-social behaviour and improving outcomes for people living with PTSD.
Disclaimer & Declaration of Interest
This podcast may contain paid promotions, including but not limited to sponsorships, endorsements, or affiliate partnerships. The information, investment views, and recommendations provided are for general informational purposes only and should not be construed as a solicitation to buy or sell any financial products related to the companies discussed. Any opinions or comments are made to the best of the knowledge and belief of the commentators; however, no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion. Listeners are encouraged to perform their own research and consult with a licensed professional before making any financial decisions based on the content of this podcast.
  continue reading

560 episodes

Artwork
iconShare
 
Manage episode 499789962 series 3002024
Content provided by The Sunday Roast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Sunday Roast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode of The Midweek Takeaway, Kevin Hornsby and Charles Archer is joined by Anthony Tennyson, CEO of Solvonis Therapeutics (LSE: SVNS), to discuss positive pre-clinical results from the company’s PTSD programme, SVN-SDN-14. Three high-performing candidates with strong, balanced SERT, DAT, and NET modulation profiles are advancing to in vivo studies — a key step toward developing a new class of medicines aimed at enhancing pro-social behaviour and improving outcomes for people living with PTSD.
Disclaimer & Declaration of Interest
This podcast may contain paid promotions, including but not limited to sponsorships, endorsements, or affiliate partnerships. The information, investment views, and recommendations provided are for general informational purposes only and should not be construed as a solicitation to buy or sell any financial products related to the companies discussed. Any opinions or comments are made to the best of the knowledge and belief of the commentators; however, no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion. Listeners are encouraged to perform their own research and consult with a licensed professional before making any financial decisions based on the content of this podcast.
  continue reading

560 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play